Aging is widely understood, yet questions about why it happens create uncertainty even among leading experts. A proposed view defines aging as a loss of cellular identity. Experimental treatments are described as a way to recover that identity, implying that aging could be reversed and many age-related diseases could be halted. A biochemist and pharmacologist who has worked for decades in the United States helped found Altos Labs, a heavily funded biotech company. The company focuses on basic science to rejuvenate human cells rather than developing a single anti-aging pill. Its aim includes addressing diseases such as cancer and Alzheimer’s. High-profile researchers and Nobel laureates joined the effort.
"Alongside Izpisua, other leading figures in aging research such as Pura Munoz left public institutions to sign contracts with Altos, where salaries can reach 1 million a year. Four Nobel laureates followed the same path. The company was a new and secretive company funded by some of the richest people on the planet with a $3 billion budget, an unprecedented sum for a biotech start-up."
Read at english.elpais.com
Unable to calculate read time
Collection
[
|
...
]